Literature DB >> 18450736

The Janus kinase 2 (JAK2) V617F mutation in Chinese patients with chronic myeloproliferative disorders.

Zhijian Xiao, Yue Zhang, Lin Li, Ling Nie, Lin Yang, Shicai Xu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18450736     DOI： 10.3324/haematol.12337

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  2 in total

1.  A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers.

Authors:  Yoichiro Ogama; Tomoko Mineyama; Asuka Yamamoto; Margaret Woo; Naomi Shimada; Taro Amagasaki; Kazuto Natsume
Journal:  Int J Hematol       Date:  2013-02-05       Impact factor: 2.490

2.  [Pathological characteristics of megakaryocytes in myeloproliferative neoplasms and their correlation with driver gene mutations].

Authors:  Z X Shi; P H Zhang; B Li; L H Fang; Z F Xu; T J Qin; J Q Liu; N B Hu; L J Pan; S Q Qu; D Liu; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.